INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 254 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is 6.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $12,051,000 | +45.8% | 470,741 | +65.6% | 10.04% | +0.1% |
| Q1 2019 | $8,264,000 | -24.9% | 284,263 | -66.1% | 10.03% | +121.0% |
| Q4 2018 | $11,007,000 | -23.8% | 838,946 | +17.5% | 4.54% | +64.0% |
| Q3 2018 | $14,440,000 | -5.6% | 714,159 | +10.4% | 2.77% | +16.8% |
| Q2 2018 | $15,298,000 | -26.0% | 646,863 | -29.6% | 2.37% | -30.4% |
| Q1 2018 | $20,685,000 | +33.0% | 918,523 | +84.1% | 3.41% | +18.8% |
| Q4 2017 | $15,556,000 | +246.2% | 498,921 | +246.5% | 2.87% | +148.1% |
| Q3 2017 | $4,494,000 | +63.7% | 144,000 | -10.0% | 1.16% | -3.3% |
| Q2 2017 | $2,746,000 | -35.6% | 160,000 | -50.3% | 1.20% | -52.1% |
| Q4 2016 | $4,261,000 | -8.9% | 322,044 | 0.0% | 2.50% | -13.1% |
| Q3 2016 | $4,676,000 | +181.2% | 322,044 | +90.9% | 2.87% | +99.5% |
| Q2 2016 | $1,663,000 | +228.0% | 168,700 | +321.8% | 1.44% | +174.3% |
| Q1 2016 | $507,000 | – | 40,000 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |